Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

被引:0
|
作者
Xiang, Shouyan [1 ,2 ]
Li, Yubei [2 ]
Khan, Shah Nawaz [2 ,3 ]
Zhang, Weixin [4 ]
Yuan, Gaoyang [1 ]
Cui, Jiahua [1 ,2 ]
机构
[1] Gannan Med Univ, Sch Pharm, Ganzhou 341000, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai 200240, Peoples R China
[3] Univ Malakand, Dept Pharm, Chakdara 18800, Pakistan
[4] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200240, Peoples R China
关键词
1,4-naphthoquinones; anticancer; antimicrobial; antiviral; structure-activity relationships; natural products; SHIKONIN OXIME DERIVATIVES; CELL-CYCLE ARREST; BIOLOGICAL EVALUATION; 1,4-NAPHTHOQUINONE DERIVATIVES; VITAMIN-K; IN-VITRO; POTASSIUM SUPEROXIDE; EFFICIENT; CANCER; ANTIFUNGAL;
D O I
10.3390/ph18030350
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cancer remains a primary cause of mortality, with over 18.1 million new cases and 9.6 million deaths globally in 2018. Chemotherapy, which utilizes a spectrum of cytotoxic drugs targeting the rapidly dividing cancer cells, is a predominant treatment modality. However, the tendency of chemotherapeutics to induce drug resistance and exhibit non-specific cytotoxicity necessitates the development of new anticancer agents with heightened efficacy and minimized toxicity. In recent years, the discovery of safe and effective antibacterial/antiviral agents has also been a hot spot in medicinal chemistry. This paper comprehensively reviews the synthesis, anticancer/antibacterial/antiviral activity, and structure-activity relationships of natural 1,4-naphthoquinones and their derivatives. It highlights their potential as efficient and low-toxicity antitumor and anti-infectious drug candidates.
引用
收藏
页数:34
相关论文
共 50 条
  • [41] Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities
    Pereira, Maria de Fatima
    Rochais, Christophe
    Dallemagne, Patrick
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (09) : 1080 - 1091
  • [42] Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents
    Zhang, Yingqian
    Wu, Chenyuan
    Zhang, Nana
    Fan, Rui
    Ye, Yang
    Xu, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [43] Recent advances in epigenetic anticancer therapeutics and future perspectives
    Ren, Liwen
    Yang, Yihui
    Li, Wan
    Yang, Hong
    Zhang, Yizhi
    Ge, Binbin
    Zhang, Sen
    Du, Guanhua
    Wang, Jinhua
    FRONTIERS IN GENETICS, 2023, 13
  • [44] Recent progress on triterpenoid derivatives and their anticancer potential
    Zhao, Zi-Xuan
    Zou, Qiong-Yu
    Ma, Ying-Hong
    Morris-Natschke, Susan L.
    Li, Xiang-Yuan
    Shi, Lin-Chun
    Ma, Guo-Xu
    Xu, Xu-Dong
    Yang, Mei-Hua
    Zhao, Zi-Jian
    Li, Yuan-Xiang
    Xue, Jing
    Chen, Chin-Ho
    Wu, Hai-Feng
    PHYTOCHEMISTRY, 2025, 229
  • [45] Feline Aortic Thromboembolism: recent advances and future prospects
    Guillaumin, Julien
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2024, 26 (06) : 1098612X241257878
  • [46] Nanofiltration membranes review: Recent advances and future prospects
    Mohammad, A. W.
    Teow, Y. H.
    Ang, W. L.
    Chung, Y. T.
    Oatley-Radcliffe, D. L.
    Hilal, N.
    DESALINATION, 2015, 356 : 226 - 254
  • [47] Recent advances and future prospects in direct cardiac reprogramming
    Yifang Xie
    Ben Van Handel
    Li Qian
    Reza Ardehali
    Nature Cardiovascular Research, 2023, 2 : 1148 - 1158
  • [48] Approaches for Imaging Islets: Recent Advances and Future Prospects
    Ahlgren, Ulf
    Gotthardt, Martin
    ISLETS OF LANGERHANS, 2010, 654 : 39 - 57
  • [49] Study on the Jehol Biota: Recent advances and future prospects
    Xing XU
    Zhonghe ZHOU
    Yuan WANG
    Min WANG
    Science China(Earth Sciences), 2020, 63 (06) : 757 - 773
  • [50] Study on the Jehol Biota: Recent advances and future prospects
    Xu, Xing
    Zhou, Zhonghe
    Wang, Yuan
    Wang, Min
    SCIENCE CHINA-EARTH SCIENCES, 2020, 63 (06) : 757 - 773